Evidence map›Paper›PMID 34935934›Full record

ArticleEuropean journal of public health2022

Impact of the first wave of the COVID-19 pandemic on cancer registration and cancer care: a European survey.

Luciana Neamţiu, Carmen Martos, Francesco Giusti, Raquel Negrão Carvalho, Giorgia Randi, Nadya Dimitrova, Manuela Flego, Tadeusz Dyba, Manola Bettio, Anna Gavin and 2 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Cancer incidence and mortality trends from 2007 to 2021 in Milan.European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) · 2026
    Article
  2. Epidemiology of Incidence and Mortality Due to Head and Neck Cancer in Poland in 2000 to 2022.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. The impact of the COVID-19 pandemic on clinical staging, pathological staging and surgical management of breast cancer patients.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2024
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. SARS-CoV-2 and cancer: the intriguing and informative cross-talk.Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis · 2022
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Luciana NeamţiuEuropean Commission, Joint Re search Centre (JRC), Ispra, Italy.
Carmen MartosEuropean Commission, Joint Re search Centre (JRC), Ispra, Italy.
Francesco GiustiEuropean Commission, Joint Re search Centre (JRC), Ispra, Italy.
Raquel Negrão CarvalhoEuropean Commission, Joint Re search Centre (JRC), Ispra, Italy.
Giorgia RandiEuropean Commission, Joint Re search Centre (JRC), Ispra, Italy.
Nadya DimitrovaEuropean Commission, Joint Re search Centre (JRC), Ispra, Italy.
Manuela FlegoEuropean Commission, Joint Re search Centre (JRC), Ispra, Italy.
Tadeusz DybaEuropean Commission, Joint Re search Centre (JRC), Ispra, Italy.
Manola BettioEuropean Commission, Joint Re search Centre (JRC), Ispra, Italy.
Anna GavinNorthern Ireland Cancer Registry, Queens University, Belfast, UK.
Otto VisserNetherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands.
ENCR Steering Committee
Joint Research Centre · ITNetherlands Comprehensive Cancer Organisation · NLThe Northern Ireland Cancer Centre · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe coronavirus disease COVID-19 pandemic posed a number of challenges to the oncology community, particularly the diagnosis and care of cancer patients while ensuring safety from the virus for both patients and professionals: minimization of visits to the hospital, cancellation of the screening programmes and the difficulties in the management and operation of cancer registries (CRs) while working remotely. This article describes the effects in the medium term of the first wave of the COVID-19 pandemic on cancer registration in Europe, focusing on changes in cancer detection and treatment, possible reduction of CR resources and difficulties in the access to data sources.

methodsA questionnaire was distributed in June 2020 to the directors of 108 CRs from 34 countries affiliated to the European Network of Cancer Registries, providing a 37% response rate.

resultsThe results of the survey showed that cancer-screening programmes were mostly stopped or slowed down in the majority of regions covered by the respondent CRs. Cancer diagnostics and treatments were severely disrupted. The cancer registration process was also disrupted, due to changes in the work modalities for the personnel, as well as to the difficulties in accessing sources and/or receiving the notifications. In some CRs, staff was allocated to different activities related to controlling the pandemic. Several CRs reported that they were investigating the impact of COVID-19 on cancer care via dedicated studies.

conclusionsA careful analysis will be necessary for proper interpretation of temporal and geographical variations of the 2020 cancer burden indicators.

Indexed as

COVID-19NeoplasmsHumansPandemicsSARS-CoV-2Surveys and Questionnaires

Identifiers

PMID34935934
PMCPMC8975538
OpenAlexW4200283516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.